In vivo experiments revealed CD8+ T cell activation in tumor tissues with elevated miR-96-5p expression, indicating that miR-96-5p may enhance macrophage-mediated antigen cross-presentation through increased tumor cell clearance. The gene discussed is CD8A; the disease is neoplasm.